|
Information was received from a patient who was implanted with an implantable neurostimulator (ins).It was reported that an "unusable setting value" message was displayed.All intensities for group a 1¿4 became 0.8, and even when the up arrow button was pressed, the "unusable setting value" issue occurred, preventing the intensity from being increased to the usual 1.4.Both the controller and ins were at 100%, and it was confirmed that adaptivestim was not used.There were groups b and c, but the patient did not change groups themselves and they were unaware of the reasons for the settings of each group.Group b had an intensity of 1.1 for all programs 1¿4, and group c had an intensity of 1.0 for all programs 1¿4.After switching groups and returning to group a, the patient attempted to lower the intensity of program 1 to 0.6 and then increase it, but an "unusable setting value" error occurred.While discussing the issue, the patient mentioned that the intensity dropped to 0.0, and they were unable to increase it due to the same error.For program 2 in group a, the intensity became 1.0 during the conversation, but the "unusable setting value" error prevented it from being increased.The cause of the sudden intensity changes could not be identified.Programs 3 and 4 remained at 0.8 without any changes.The patient experienced constant pain 24 hours a day and noted that the sensation of stimulation did not significantly vary regardless of the group or intensity.It was suggested to either leave the settings as they were and observe the issue, or wait for some time and try again.At the end of the conversation, the patient mentioned that their arm started feeling strange when the intensity of program 1 in group a dropped to 0.0.As a result, the group was switched to group b to monitor the situation.Details about what was strange with the arm could not be confirmed.The patient was advised to consult a medical institution if the situation did not improve through controller operation or if there were any health concerns.The issue was not resolved.No further information was available.
|
|
G2: the country of origin is japan.Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
|